While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: RSCOV-CACE2HE
$1,900.00
Ready-to-use cells engineered to stably express the the ACE2 receptor. These cells are susceptible to infection by viruses expressing the SARS virus spike protein, including SARS-CoV-2-S pseudotyped lentivirus, so they can be used for neutralization assays and related studies looking at viral binding.
Catalog # | Description | Vector |
RSCOV-CACE2HE |
HeLa cells |
HeLa-ACE2 Cells (for SARS-CoV-S, SARS-CoV2-S, SARS-CoV2-S-D614G assays) |
RSCOV-CACE2U2 |
U2OS cells |
U2OS-ACE2 (for SARS-CoV-S and SARS-CoV2-S, SARS-CoV2-S-D614G assays) |
Coming Soon